A peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of lymphoma and myeloma.
This unique, focused journal is devoted to articles on detection, diagnosis, prevention, and treatment of lymphoma, myeloma, and related disorders including macroglobulinemia, amyloidosis, and plasma-cell dyscrasias. The main emphasis is on recent scientific developments in all areas related to lymphoma and myeloma.
Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.
Clinical Lymphoma, Myeloma & Leukemia was published as Clinical Lymphoma & Myeloma through December 2009.